Fisher Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-523,394
| Closed | -$1.2M | – | 1232 |
|
|
2023
Q2 | $1.2M | Sell |
523,394
-126,332
| -19% | -$289K | ﹤0.01% | 743 |
|
|
2023
Q1 | $1.58M | Sell |
649,726
-70,517
| -10% | -$171K | ﹤0.01% | 690 |
|
|
2022
Q4 | $1.38M | Buy |
720,243
+114,715
| +19% | +$219K | ﹤0.01% | 716 |
|
|
2022
Q3 | $1.45M | Hold |
605,528
| – | – | ﹤0.01% | 623 |
|
|
2022
Q2 | $1.13M | Buy |
605,528
+237,334
| +64% | +$441K | ﹤0.01% | 616 |
|
|
2022
Q1 | $770K | Buy |
368,194
+197,424
| +116% | +$413K | ﹤0.01% | 653 |
|
|
2021
Q4 | $673K | Buy |
+170,770
| New | +$673K | ﹤0.01% | 703 |
|